Join
Live feed
·
INSIDERFilingvia Quantisnow
Biodesix Inc. logo

Chief Commercial Officer O'Kane Kieran converted options into 805 shares and sold $2,428 worth of shares (298 units at $8.15), increasing direct ownership by 7% to 7,869 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BDSX· Biodesix Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BDSX (Biodesix Inc.) and more on Quantisnow.